Results 161 to 170 of about 1,576 (207)

Establishing the First Genetic Variant Registry for Breast and Ovarian Cancer in Colombia: Insights and Implications. [PDF]

Diseases
Deugd R, Riano JC, de Vries E, Cardona AF, Rodriguez J, Fidalgo-Zapata A, Sanchez Y, Sanchez S, Olaya J, de Leon D, Ossa CA, Reynales H, Quintero P, Vargas E, Hamann U, Torres D.   +15 more
europepmc   +1 more source

Human Leukocyte Antigen Class I Expression and Natural Killer Cell Infiltration and Its Correlation with Prognostic Features in Luminal Breast Cancers. [PDF]

Breast Cancer (Dove Med Press)
Vernet-Tomas M, Vazquez I, Olivares F, Lopez D, Yelamos J, Comerma L.   +5 more
europepmc   +1 more source

[Cancer prevention recommendations: Update 2024]. [PDF]

Aten Primaria
Bartolomé-Moreno C, Melús-Palazón E, Vela-Vallespín C, Arana-Ballestar S, Gallego M, Navarro J, Bellas-Beceiro B, Grupos de expertos del PAPPS.   +7 more
europepmc   +1 more source

[Perceived stress in Mexican patients newly diagnosed with breast cancer]. [PDF]

Rev Med Inst Mex Seguro Soc
Neri-Flores V, Gálvez-Hernández CL, Riveros-Rosas A, Arce-Salinas CH, Acosta-Quiroz CO, Del Río-Portilla F IY.   +5 more
europepmc   +1 more source

Unraveling malignant phenotype of peritumoral tissue: transcriptomic insights into early-stage breast cancer. [PDF]

Breast Cancer Res
Morla-Barcelo PM, Laguna-Macarrilla D, Cordoba O, Matheu G, Oliver J, Roca P, Nadal-Serrano M, Sastre-Serra J.   +7 more
europepmc   +1 more source

Talimogene laherparepvec and atezolizumab in HER2-negative breast cancer following neoadjuvant chemotherapy: a window-of-opportunity phase II trial (SOLTI-1503 PROMETEO). [PDF]

Nat Commun
Pascual T, Vidal M, Cejalvo JM, Vega E, Sanfeliu E, Villacampa G, Ganau S, Parreño AMJ, Zamora E, Miranda I, Delgado A, Bermejo B, Seguí E, Brasó-Maristanty F, de la Cruz-Merino L, Juan M, Galván P, Gonzàlez-Farré X, Chillara S, Villagrasa P, Pfefferle AD, O'Connell CE, Ferrero-Cafiero JM, Oliveira M, Perou CM, Prat A.   +25 more
europepmc   +1 more source

Oncological outcomes of selective axillary dissection with 4% carbon marking. [PDF]

Rev Col Bras Cir
Budel LR, Spautz CC, Louveira MH, Cavalcanti TCS, Fornazari AC, Gasperin Junior P, Nissen L, Budel VM.   +7 more
europepmc   +1 more source

Impacto clinicobiológico del grado histológico en pacientes afectas de carcinomas ductales infiltrantes de mama

, 2012
Herranz Carnero, Michel, Ruibal Morell, Alvaro, Arce Calisaya, Patricia, Cortés Hernández, Julia, Garrido Pumar, Miguel, Nieves Maldonado, Shirly Margarita, Sánchez Salmón, Aida, López Urdaneta, Jesús Miguel   +7 more
openaire   +1 more source